What changedvs. the 10-Q for 2026 Q1 — 5 notable changesView full comparison
    • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Added: “The Section 122 tariffs expired on July 24, 2026 and the Administration subsequently announced new tariffs under Section 301 of the Trade Act of 1974, including tariffs ranging from 10% to 12.5% on imports from certain countries. In addition, the U.S. Department of Commerce…”
    • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Rewritten: “$2.7 million in stock based compensation and $1.1 million in professional services, which were combined with other smaller category increases and decreases. Stock based compensation decreased driven by the timing of our equity award vestings, which resulted in one less…”
    • Note 4: Disposal of Business — Added: “(1) During the three and six months ended June 30, 2026, we recorded non-cash impairment charges to reduce the carrying value of operating lease ROU assets to their estimated fair values, driven by the early exit of the facilities as we integrate the Smiths Medical business…”
    • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Added: “IT expenses decreased primarily due to lower computer maintenance costs and lower outsourced data processing costs as a result of integration synergies. Facilities expenses decreased primarily due to a decrease in rent expense as a result of the expiration and exit of certain…”
    • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Added: “The effective tax rate during the three and six months ended June 30, 2025 included a tax expense of $6.1 million related to the sale of a 60% interest of our IV solutions business. Additionally, there were unrecognized tax benefits released as a result of the expiration of…”

    This is a text-only preview. Log in or sign up to view the full document.

    Forward-Looking Statements

    This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements, other than statements of historical fact, contained in this Quarterly Report on Form 10-Q, including, without limitation, statements regarding: our future results of operations and financial position, including expected decreases in restructuring costs, business strategy and approach; the anticipated benefits and costs associated with our purchase agreement with Otsuka Pharmaceutical Factory America, Inc. ("OPF"); expected capital expenditures; anticipated consumer demand; supply chain constraints; timing and resolution of the 2025 Warning Letter (as defined below); the expected impact of macroeconomic developments, such as foreign exchange, inflation and interest rates, and new accounting and tax regulations; tariffs and the timing and receipt of any potential future refunds; the impact of the One Big Beautiful Bill Act (the "OBBBA"); as well as plans and objectives of management for future operations, are forward-looking statements. Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seeks,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance, or achievements, and one should avoid placing undue reliance on such statements.

    Sign up or log in to view this filing

    Create a free CapEdge account to read the full document, search inside it, and export tables.